We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.
Amey Sutkowski is a Director in the International Advocacy Department at PhRMA, where she focuses on market access policies and pricing and reimbursement systems around the globe. Amey earned her Master of Public Policy from the University of Michigan and completed her undergraduate studies at Cornell University.
Innovative medicines improve patient outcomes and can yield significant economic savings. The introduction of a medicine by 2020 that delays the onset of Alzheimer’s disease by just five years...
Since a peak in 1991, cancer mortality rates have declined by as much as 27% around the world. These gains in cancer survival are largely attributed to new and innovative therapies. According to...